Parallax Volatility Advisers’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Parallax Volatility Advisers’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,504	Closed	-$25.8K	–	4030
2018 Q2	$21K	Buy	+1,504	New	+$17.8K	﹤0.01%	1687
2018 Q1	–	Sell	-7,613	Closed	-$33K	–	5173
2017 Q4	$33K	Sell	7,613 -80,307	-91%	-$383K	﹤0.01%	3451
2017 Q3	$124K	Hold	87,920	–	–	﹤0.01%	1562
2017 Q2	$132K	Buy	87,920 +57,742	+191%	+$124K	﹤0.01%	1580
2017 Q1	$78K	Buy	+30,178	New	+$69.8K	﹤0.01%	2381

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Parallax Volatility Advisers's ECYT Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2018, closing a stake of 1,504 shares — an estimated $25.8K sold.

Parallax Volatility Advisers first reported a position in ECYT in Q1 2017 and held it in 5 quarters. The position peaked at $132K in Q2 2017. 139 funds tracked by Wall St. Rank hold ECYT as of Q3 2018.

Parallax Volatility Advisers reported no remaining Endocyte, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 1,504 Endocyte, Inc. Common Stock shares in Q3 2018, an estimated $25.8K.
Parallax Volatility Advisers first reported a position in Endocyte, Inc. Common Stock in Q1 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Endocyte, Inc. Common Stock position peaked at $132K in Q2 2017.
139 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.